3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3benzodiazepine-2(1H)-one

Details for Australian Patent Application No. 2006331404 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Schnaubelt, Juergen; Krueger, Thomas; Stehle, Emanuel

Agent Davies Collison Cave

Pub. Number AU-A-2006331404

PCT Pub. Number WO2007/074130

Priority 05028476.9 24.12.05 EP

Filing date 21 December 2006

Wipo publication date 5 July 2007

International Classifications

C07D 243/04 (2006.01) Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

Event Publications

31 July 2008 PCT application entered the National Phase

  PCT publication WO2007/074130 Priority application(s): WO2007/074130

19 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006331425-User customizable drop-down control list for GUI software applications

2006331391-Amorphous caesium aluminium fluoride complex, its production and use